- Home
- RVPH vs BIDU Comparison
RVPH vs BIDU Comparison
Compare RVPH & BIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- BIDU
- Stock Information
- Founded
- RVPH 2006
- BIDU 2000
- Country
- RVPH United States
- BIDU China
- Employees
- RVPH N/A
- BIDU N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- BIDU Computer Software: Programming Data Processing
- Sector
- RVPH Health Care
- BIDU Technology
- Exchange
- RVPH Nasdaq
- BIDU Nasdaq
- Market Cap
- RVPH 32.8M
- BIDU 28.5B
- IPO Year
- RVPH N/A
- BIDU 2005
- Fundamental
- Price
- RVPH $0.40
- BIDU $87.00
- Analyst Decision
- RVPH Strong Buy
- BIDU Strong Buy
- Analyst Count
- RVPH 5
- BIDU 10
- Target Price
- RVPH $9.00
- BIDU $111.60
- AVG Volume (30 Days)
- RVPH 3.4M
- BIDU 2.2M
- Earning Date
- RVPH 08-13-2025
- BIDU 08-21-2025
- Dividend Yield
- RVPH N/A
- BIDU N/A
- EPS Growth
- RVPH N/A
- BIDU 34.31
- EPS
- RVPH N/A
- BIDU 10.01
- Revenue
- RVPH N/A
- BIDU $18,475,022,401.00
- Revenue This Year
- RVPH N/A
- BIDU $3.12
- Revenue Next Year
- RVPH N/A
- BIDU $5.62
- P/E Ratio
- RVPH N/A
- BIDU $8.68
- Revenue Growth
- RVPH N/A
- BIDU N/A
- 52 Week Low
- RVPH $0.30
- BIDU $74.71
- 52 Week High
- RVPH $4.28
- BIDU $116.25
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- BIDU 50.28
- Support Level
- RVPH $0.35
- BIDU $84.82
- Resistance Level
- RVPH $0.83
- BIDU $91.25
- Average True Range (ATR)
- RVPH 0.06
- BIDU 1.40
- MACD
- RVPH -0.01
- BIDU 0.24
- Stochastic Oscillator
- RVPH 17.36
- BIDU 47.04
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.